Axis,Extreme1,Extreme2
Delivery Method,Invasive,Non-invasive
Treatment Customization,Generic,Precision Medicine
Biocompatibility,Low,High
Scalability,Not Scalable,Scalable
Economic Viability,High Cost,Low Cost
